Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trial
Cortés, Javier, Dr, Dieras, Véronique, MD, Ro, Jungsil, MD, Barriere, Jérôme, MD, Bachelot, Thomas, MD, Hurvitz, Sara, MD, Le Rhun, Emilie, MD, Espié, Marc, MD, Kim, Sung-Bae, MD, Schneeweiss, Andreas, MD, Sohn, Joo Hyuk, MD, Nabholtz, Jean-Marc, Prof, Kellokumpu-Lehtinen, Pirkko-Liisa, Prof, Taguchi, Julie, MD, Piacentini, Federico, MD, Ciruelos, Eva, MD, Bono, Petri, MD, Ould-Kaci, Mahmoud, MD, Roux, Flavien, MSc, Joensuu, Heikki, Prof
Published in The lancet oncology (01.12.2015)
Published in The lancet oncology (01.12.2015)
Get full text
Journal Article
Evaluation of Tumor Response, Disease Control, Progression-Free Survival, and Time to Progression As Potential Surrogate End Points in Metastatic Breast Cancer
BURZYKOWSKI, Tomasz, BUYSE, Marc, JASSEM, Jacek, BONTENBAL, Marijke, BONNETERRE, Jacques, STEPHEN CHAN, BASARAN, Gul Atalay, THERASSE, Patrick, PICCART-GEBHART, Martine J, SLEDGE, George, CARMICHAEL, James, LÜCK, Hans-Joachim, MACKEY, John R, NABHOLTZ, Jean-Marc, PARIDAENS, Robert, BIGANZOLI, Laura
Published in Journal of clinical oncology (20.04.2008)
Published in Journal of clinical oncology (20.04.2008)
Get full text
Journal Article
Breast-cancer detection using blood-based infrared molecular fingerprints
Kepesidis, Kosmas V, Bozic-Iven, Masa, Huber, Marinus, Abdel-Aziz, Nashwa, Kullab, Sharif, Abdelwarith, Ahmed, Al Diab, Abdulrahman, Al Ghamdi, Mohammed, Hilal, Muath Abu, Bahadoor, Mohun R K, Sharma, Abhishake, Dabouz, Farida, Arafah, Maria, Azzeer, Abdallah M, Krausz, Ferenc, Alsaleh, Khalid, Zigman, Mihaela, Nabholtz, Jean-Marc
Published in BMC cancer (02.12.2021)
Published in BMC cancer (02.12.2021)
Get full text
Journal Article
Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer
PICCART-GEBHART, Martine J, BURZYKOWSKI, Tomasz, JASSEM, Jacek, BONTENBAL, Marijke, BONNETERRE, Jacques, CHAN, Stephen, BASARAN, Gul Atalay, THERASSE, Patrick, BUYSE, Marc, SLEDGE, George, CARMICHAEL, James, LÜCK, Hans-Joachim, MACKEY, John R, NABHOLTZ, Jean-Marc, PARIDAENS, Robert, BIGANZOLI, Laura
Published in Journal of clinical oncology (20.04.2008)
Published in Journal of clinical oncology (20.04.2008)
Get full text
Journal Article
Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma : Results of two randomized trials designed for combined analysis
BONNETERRE, Jacques, BUZDAR, Aman, NABHOLTZ, Jean-Marc A, ROBERTSON, John F. R, THÜRLIMANN, Bert, VON EUTER, Mikael, SAHMOUD, Tarek, WEBSTER, Alan, STEINBERG, Mark
Published in Cancer (01.11.2001)
Published in Cancer (01.11.2001)
Get full text
Journal Article
Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy and anti-EGFR antibodies
Radosevic-Robin, Nina, Selenica, Pier, Zhu, Yingjie, Won, Helen H., Berger, Michael F., Ferrando, Lorenzo, Cocco, Emiliano, Privat, Maud, Ponelle-Chachuat, Flora, Abrial, Catherine, Nabholtz, Jean-Marc, Penault-Llorca, Frederique, Reis-Filho, Jorge S., Scaltriti, Maurizio
Published in NPJ breast cancer (17.09.2021)
Published in NPJ breast cancer (17.09.2021)
Get full text
Journal Article
Curcumin's effect in advanced and metastatic breast cancer patients treated with first or second‐line docetaxel: A randomized trial
Judith, Passildas Jahanmohan, Maureen, Bernadach, Mélanie, Pouget, Fabrice, Kwiatkowski, Isabelle, Vanpraagh‐Doreau, Pascale, Dubray‐Longeras, Catherine, Abrial, Jean‐Marc, Nabholtz, Hervé, Curé, Valérie, Delecroix, Philippe, Chollet, Marie‐Ange, Mouret‐Reynier
Published in Health science reports (01.09.2024)
Published in Health science reports (01.09.2024)
Get full text
Journal Article
Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III Trial
NABHOLTZ, Jean-Marc, FALKSON, Carla, VOROBIOF, Daniel, LEONARD, Robert, KENNEDY, Ian, AZLI, Nacer, MURAWSKY, Michael, RIVA, Alessandro, POUILLART, Pierre, CAMPOS, Daniel, SZANTO, Janos, MARTIN, Miguel, CHAN, Stephen, PIENKOWSKI, Tadeuz, ZALUSKI, Jerzy, PINTER, Tamas, KRZAKOWSKI, Maciej
Published in Journal of clinical oncology (15.03.2003)
Published in Journal of clinical oncology (15.03.2003)
Get full text
Journal Article
Randomized Phase III Trial of Pegylated Liposomal Doxorubicin Versus Vinorelbine or Mitomycin C Plus Vinblastine in Women With Taxane-Refractory Advanced Breast Cancer
KELLER, Alan M, MENNEL, Robert G, MELLARS, Lillian, ALLAND, Leila, TENDLER, Craig, GEORGOULIAS, Vassilis A, NABHOLTZ, Jean-Marc, ERAZO, Aura, LLUCH, Anna, VOGEL, Charles L, KAUFMANN, Manfred, VON MINCKWITZ, Gunther, HENDERSON, I. Craig
Published in Journal of clinical oncology (01.10.2004)
Published in Journal of clinical oncology (01.10.2004)
Get full text
Journal Article
Response to Induction Neoadjuvant Hormonal Therapy Using Upfront 21-Gene Breast Recurrence Score Assay—Results From the SAFIA Phase III Trial
AlSaleh, Khalid, Al Zahwahry, Heba, Bounedjar, Adda, Oukkal, Mohammed, Saadeddine, Ahmed, Mahfouf, Hassen, Bouzid, Kamel, Bensalem, Assia, Filali, Taha, Abdel-Razeq, Hikmat, Larbaoui, Blaha, Kandil, Alaa, Abulkhair, Omalkhair, Al Foheidi, Meteb, Errihani, Hassan, Ghosn, Marwan, Abdel-Aziz, Nashwa, Arafah, Maria, Boussen, Hamouda, Dabouz, Farida, Rasool, Haleem, Bahadoor, Mohun, Ayari, Jihen, Kullab, Sharif, Nabholtz, Jean-Marc
Published in JCO global oncology (01.12.2021)
Published in JCO global oncology (01.12.2021)
Get full text
Journal Article
Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?
Wang-Lopez, Qian, Chalabi, Nassera, Abrial, Catherine, Radosevic-Robin, Nina, Durando, Xavier, Mouret-Reynier, Marie-Ange, Benmammar, Kheir-Eddine, Kullab, Sharif, Bahadoor, Mohun, Chollet, Philippe, Penault-Llorca, Frédérique, Nabholtz, Jean-Marc
Published in Critical reviews in oncology/hematology (01.07.2015)
Published in Critical reviews in oncology/hematology (01.07.2015)
Get full text
Journal Article
Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial
Ginzac, Angeline, Molnar, Ioana, Durando, Xavier, Motte Rouge, Thibault De La, Petit, Thierry, D’hondt, Véronique, Campone, Mario, Bonichon-Lamichhane, Nathalie, Venat Bouvet, Laurence, Levy, Christelle, Augereau, Paule, Pistilli, Barbara, Arsene, Olivier, Jouannaud, Christelle, Nguyen, Suzanne, Cayre, Anne, Tixier, Lucie, Mahier Ait Oukhatar, Céline, Nabholtz, Jean-Marc, Penault-Llorca, Frédérique, Mouret-Reynier, Marie-Ange
Published in Breast cancer research and treatment (01.06.2024)
Published in Breast cancer research and treatment (01.06.2024)
Get full text
Journal Article
Docetaxel-anthracycline combinations in metastatic breast cancer
Get full text
Conference Proceeding
Journal Article